Bactroban (Mupirocin) 0.2%, Edetate Disodium (EDTA) 1%, Gentamicin 0.5%

MARCoNS (mulitiple antibiotic resistant coagulase negative staphylococci) is an antibiotic resistant staph infection that resides deep within the sinus cavity in patients suffering from biotoxin illness. These resistant bacteria form biofilm making it hard for many antibiotics to penetrate, sheltering the bacteria. BEG nasal spray is a compounded prescription treatment offered by Park Compounding Pharmacy to treat biotoxin illness.

What’s in BEG Nasal Spray?

BEG nasal spray is an effective way to eradicate colonization of biofilm-forming MARCoNS in the sinus cavity. BEG nasal spray’s active ingredients are a combination of two antibiotics (Bactroban, Gentamicin) and the calcium chelator EDTA. The EDTA dissolves the biofilm coating, clearing the way for a direct attack by the topical antibiotics.

Mold Toxicity Treatment Protocols

This combination nasal spray is a part of multiple treatments protocols for treating mold toxicity and other environmentally acquired illnesses. It is frequently combined with other treatments like cholestyramine to help fully eradicate resistant infections after mold exposure.

Research

State of the Art Review: Current Status of Topical Nasal Antimicrobial Agents – Laryngoscope

Topical Antimicrobials in the Management of Chronic Rhinosinusitis: A Systematic Review – American Journal of Rhinology and Allergy